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The aminoglycoside kasugamycin, which has previously been shown to inhibit initiation of protein biosyn- 
thesis in vitro, also affects translational accuracy in vitro. This is deduced from the observation that the 
drug decreases the incorporation of histidine relative to alanine into the coat protein of phage MS2, the 
gene of which is devoid of histidine codons. The read-through of the MS2 coat cistron, due to frameshifts 
in vitro, is also suppressed by the antibiotic. In contrast, streptomycin enhances histidine incorporation and 
read-through in this system. The effects of kasugamycin take place at concentrations that do not inhibit 
coat protein biosynthesis. Kasugamycin-resistant mutants (ksgA) lacking dimethylation of two adjacent 
adenosines in 16 S ribosomal RNA, show an increased leakiness of nonsense and frameshift mutants (in 
the absence of antibiotic). They are therefore phenotypically similar to previously described ribosomal ambi- 
guity mutants (ram). 
Kasugamycin Translational fidelity 
1. INTRODUCTION 
The antibiotic kasugamycin does not, like many 
other aminoglycosides, cause mistranslation in 
cell-free systems of Escherichia coli [l]. Instead it 
has been shown to inhibit initiation of protein 
biosynthesis in vitro [2] without affecting elonga- 
tion on natural mRNA [3,4]. Sensitivity is a pro- 
perty of the 30 S ribosomal particle and resistance 
is caused by lack of dimethylation of two adjacent 
adenosines near the 3 ‘-end of 16 S RNA [5,6]. 
This is due to a mutation in the ksgA gene coding 
for a methyltransferase that is specific for this site 
in ribosomal RNA [6]. Since the importance of the 
3 ‘-terminus of 16 S RNA in initiation of protein 
biosynthesis is generally acknowledged [7], the 
selective effect of kasugamycin on initiation lends 
further support to the putative function of this 
ribosomal site. 
We re-examined the effect of kasugamycin on 
coding fidelity in vitro. For this we used a very sen- 
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ksgA 
sitive system, i.e., the incorporation of histidine in- 
to the coat protein of phage MS2, the gene of 
which does not contain in-phase histidine codons 
[8]. Our results show that kasugamycin increases 
accuracy of translation in vitro, an effect opposite 
to that caused by streptomycin. 
We find that ksg_4 mutants display an increased 
leakiness of certain nonsense and frameshift muta- 
tions, and therefore phenotypically resemble 
ribosomal ambiguity mutants [9- 111. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains 
E. coli 413 and its kasugamycin-resistant 
derivative (compare below) were used as a source 
of extracts for in vitro protein synthesis. E. coli 
strains carrying nonsense mutations in the I-gene 
part of F’ 1acIZ fusions, originating from [12] 
were obtained through the courtesy of D. 
Andersson [ 131. These strains are further described 
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in table 2. The E. coli strain no.37 containing 
Newton’s frameshift mutation ICR38 in 1acZ [14], 
was a gift from J. Gallant [15]. Spontaneous 
mutants resistant to at least 250 pg/ml 
kasugamycin (obtained at a frequency of 10e6) or 
to 100 pg/ml streptomycin were isolated from agar 
plates. The kasugamycin-resistant strains were 
tested for the k.sgA genotype by determining the 
absence of a functional methyltransferase in cell- 
free extracts [16]. 
2.2. Antibiotics 
Kasugamycin l/2 H2S04 (A4r 428.4) was pur- 
chased from Boehringer, Mannheim. Strep- 
tomycin was from Rhone-Poulenc. 
2.3. In vitro protein synthesis 
Extracts (S30) were prepared from E. coli either 
by grinding with Alcoa or by sonication. Cell 
debris was removed by centrifugation at 30000 x 
g. Assays for in vitro protein synthesis contained in 
a volume of 50~1: 40 mM Tris-HCI (pH 7.5), 
60 mM NH&l, 9 mM MgAc2, 6 mM 2-mercapto- 
ethanol, 1 mM ATP, 0.12 mM GTP, 5 mM phos- 
phoenolpyruvate, 0.1 pg pyruvate kinase, 20 pg 
uncharged tRNA, 0.3 A260 units of dialyzed S30 
extract, 8 pg MS2 RNA, 4 x 10d3 prnol each of all 
amino acids minus alanine and histidine, 0.27 x 
low3 prnol L-[3H]histidine (8222 dpm/pmol) and 
1.10 x 10m3 pmol L-[r4C]alanine (168 dpm/pmol). 
The concentration of antibiotics, which were 
always added at zero time, is given in tables, 
figures and legends. 
After incubation (25 min at 37°C) the proteins 
were precipitated with 10% trichloroacetic acid, 
washed 3 times with 10% trichloroacetic acid and 
twice with 96% alcohol, and electrophoresed on 
15% polyacrylamide gels [17]. In vitro labelled 
[14C]MS2 coat protein was included in one slot as 
a marker. The gels were autoradiographed [181, 
the bands containing the coat protein product were 
cut from the gels and burned in a Packard Oxidizer 
to separate 3H and 14C isotopes. 
2.4. &Galactosidase assay 
All bacteria used except strain no.37 (ICR38) 
synthesize ,&-galactosidase constitutively. Cells 
were cultured in 25 ml minimal medium contain- 
ing 1 mM isopropyl-P-D-thiogalactopyranoside 
(IPTG) in the case of strain no.37. After 
120 
harvesting and washing the cells were disrupted by 
sonication in 1 ml buffer (10 mM Tris-HCI (pH 
7.5), 60 mM NH&I, 10 mM MgAc2, 6 mM 
2-mercaptoethanol). Cells from 25 ml of log-phase 
cultures were collected by centrifugation, 
resuspended in 1 ml buffer and sonicated. 
Debris was removed and 200~1 of the superna- 
tant was assayed by measuring the hydrolysis of O- 
nitrophenyl-P-D-galactoside (ONPG) [ 191. Protein 
was determined by the Lowry method. Activities 
were expressed as AA&h per ,ug protein (cf. table 
2). 
3. RESULTS 
3.1. In vitro experiments 
A mixture of [3H]histidine and [14C]alanine, an 
amino acid that appears 14 times in the coat pro- 
tein of MS2 [B], was added to a MS2 RNA directed 
cell-free system. The proteins were separated by gel 
electrophoresis to detect the coat protein product 
by autoradiography. The coat protein band was 
then cut from the gel and the slices burned in an 
oxidizer that separates the 14C02 and [3H]H20. By 
using proper controls the molar incorporation of 
both amino acids was determined. Table 1 shows 
that in the absence of drugs roughly one histidine 
residue is incorporated into the coat protein for 
every 70-85 alanine residues. With extracts from 
wild-type E. co/i, kasugamycin reduces the misin- 
corporation of histidine by a factor of two, while 
streptomycin enhances the incorporation of the 
‘wrong’ amino acid 2-3-fold. Kasugamycin 
obliterates the miscoding effect of streptomycin in 
this system (table 1). With an extract from a 
kasugamycin-resistant mutant (ksgA) of E. coli, 
kasugamycin has no effect on the relative incor- 
poration of histidine, while the effect of strep- 
tomycin is the same as in the wild-type extract. 
It is important to note that the effect of 
kasugamycin on the fidelity of in vitro translation 
is recorded at drug concentrations that hardly in- 
fluence the amount of synthesized coat protein. 
This is most clearly shown in fig. 1. The incorpora- 
tion of alanine into coat protein is not affected by 
kasugamycin concentrations up to 400pg/ml in 
this system, but the level of histidine incorporation 
is reduced 3-fold (compare section 4). The MS2 
RNA-directed system allows the detection of an 
additional effect of streptomycin and kasugamycin 
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Effect of antibiotics on the error frequency in in vitro synthesized MS2 coat protein 
Exp. 
1 
3 
Genotype 
wild-type 
wild-type 
/rsgA mutant 
Antibiotic @g/ml) 
- 
kasugamycin (200) 
streptomycin (0.08) 
_ 
kasugamycin (200) 
streptomycin (0.08) 
kasugamycin (200) and 
streptomycin (0.08) 
- 
kasugamycin (200) 
streptomycin (0.08) 
Histidine/alanine 
1.18 x 1O-2 (l/85) 
0.63 x 1O-2 (11159) 
3.70 x 1O-2 (l/27) 
1.41 x 1o-2 (l/71) 
0.67 x 1O-2 (l/149) 
2.57 x 1O-2 (l/39) 
1.45 x 1O-2 (l/69) 
1.23 x 1O-2 (l/81) 
1.19 x 1O-2 (l/84) 
3.42 x 1O-2 (l/31) 
The coat protein bands were cut from gels such as shown in fig. 1. The gel slices were 
burned in an oxidizer (Packard) separating 3H and 14C isotopes. Radioactivities were 
converted to pmol amino acids and the table shows the molar ratios between 
incorporated histidine and alanine. The alanine incorporation in the controls 
(- antibiotics) corresponds to 40.3, 49.1 and 36.3 pmol, respectively. Overall 
inhibition of protein synthesis in the sensitive system was approx. 35% with 
kasugamycin and 50% with streptomycin 
loo 200 300 an 
[kasugwnycn~(pg/ml) 
C 
Fig. 1. Differential effect of kasugamycin on coat protein synthesis and on histidine incorporation. Standard mixtures 
containing wild-type E. co/i extracts were incubated with increasing amounts of kasugamycin. (A) Autoradiogram of 
the products; lane 1: marker “C-labelled coat protein; lane 2: incubation mixture lacking MS2 RNA; lanes 3-8: 
containing 0, 25, 50, 100, 200 and 400 pg/ml kasugamycin, respectively; lane 9: containing 0.08 pg/ml streptomycin. 
(B) Same gel as in (A) after removal of the band of coat protein and prolonged exposure. Arrow indicates read-through 
proteins. (C) Dependence of alanine incorporation and of histidine/alanine ratio in coat protein product on 
kasugamycin concentration. 100% alanine incorporation corresponds to 28 pmol. 
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Table 2 
Leakiness of nonsense and frameshift mutan&’ 
Designationb 
F’ UD364 Ksg resistant 
F’ UD365 Ksg resistant 
F’ UD366 Ksg resistant 
F’ UD367 Ksg resistant 
F’ UD368 Ksg resistant 
F’ UD368 Str esistant 
F’ UD471 Ksg resistant 
Lac-genotype Position of ‘ContexY @gal. activity in resistant strain)c/ 
nonsense v-gal. activity in sensitive strain) 
F’ IacIZ fusion 189 CCAClAAAGU 1.3 
F’ IacZZ fusion 189 CCAUAGAGU 1.3 
F’ IacZZ fusion 189 CCA CJGA AGU 1.5 
F ’ IacZZ fusion 220 GACCJAAAGU 1.2 
F ’ IacZZ fusion 220 GAC(IAGAGU 1.9 
F’ IacZZ fusion 220 GACUAGAGU 0.1 
F’ IacZZ fusion 220 GACLrGAAGU 1.2 
no.37 Ksg resistant lacZ ICR38 
no.37 Str resistant 1acZ ICR38 
a These mutants have been described in detail [12-15,251 
b Ksg: kasugamycin; Str: streptomycin 
1.8 
0.68 
’ P-gal. activity varied from 1.53 x 10m4 A42,Jh per pg protein (UD368) to 1.15 x 10m3 A&h per pg protein (no.37) 
related to fidelity. This is illustrated in fig. 1B. Two 
bands in the autoradiogram (arrow in fig.lB) 
originate from ‘read-through’ products caused by 
ribosomal frameshifts during translation of the 
coat protein cistron [20]. Streptomycin (lane 9, 
fig.lB and [21]) increases the relative amounts of 
these two proteins, while kasugamycin strongly 
reduces these products (lanes 3-8, fig.1). Hence, 
kasugamycin diminishes ribosomal frameshifts, at 
least in vitro. 
3.2. Leakiness of nonsense and frameshift 
mutants in ksgA strains 
Streptomycin-resistant mutants (strA) show an 
increased fidelity in vivo while ram mutants are 
less stringent in translation than wild-type cells 
[22]. Ribosomal stringency and ambiguity in vivo 
can be determined by the expression of nonsense 
and frameshift mutations in a suppressor-minus 
genetic background [13,22-241. We made use of 
well-characterized nonsense mutants in IacIZ gene 
fusions [12,13,25] and of a frameshift mutant in 
1acZ [ 14,151. Kasugamycin- and streptomycin- 
resistant mutants of these strains were selected 
after spontaneous mutation. The ksgA genotype 
was established by determining the lack of the 
specific methyltransferase and the presence of 
ribosomes lacking dimethylation of 16 S RNA 
[ 161. The ,&galactosidase activities in the ksgA 
mutants were compared to those of the isogenic 
ksgA+ type (table 2). The IacZZ nonsense mutants 
and the 1acZ frameshift mutant became more leaky 
in the ksgA background. The increase varied from 
1.2 to 1.9, depending on the nature of the mutation 
and on the ‘context’. In comparable studies on the 
effect of ram (rpsD coding for ribosomal protein 
S4) using the same IacIZ fusion mutants, the in- 
crease in leakiness varied 2- to 50-fold [ 131. Other 
ram mutants were found to ‘suppress’ nonsense in 
the ornithine transcarbamoylase gene by a factor 
of 2-6 [24]. 
The effect of mutation to streptomycin 
resistance (table 2) is as expected and in good 
agreement with previous work with these nonsense 
and frameshift mutants [23,25]. Since reinitiation 
of protein synthesis can take place subsequent o 
termination in the IacZ gene [26] and in the 1acZ 
gene [27] it was important to rule this out as the 
cause of leakiness. By determining the size of the 
,&galactosidase made in vivo in one of the ksgA 
mutants we could exclude reinitiation as a cause of 
leakiness (not shown). 
Unlike with strA and ram mutants [9] we have 
been unable to detect ribosomal ambiguity of ksgA 
ribosomes in vitro (compare table 1, exp.3). Pro- 
bably this system is not sensitive enough to detect 
a difference with wild-type ribosomes. 
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4. DISCUSSION ACKNOWLEDGEMENTS 
Our results show clearly that the antibiotic 
kasugamycin, in addition to its inhibitory effect on 
initiation of protein biosynthesis [2,29], increases 
the accuracy of translation in vitro. Both the 
misincorporation of histidine in MS2 coat protein 
and the read-through of the coat protein gene are 
counteracted by the antibiotic. These activities are 
exerted by the antibiotic at concentrations lower 
than those giving inhibition of synthesis of coat 
protein. 
The authors thank Drs J. Gallant and D.I. 
Andersson for providing strains carrying nonsense 
and frameshift mutations, and M.P. Lawson for 
contributing to the experiments. 
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